{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:57:20Z","timestamp":1768481840795,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/mnm.0b013e3280708ecf","type":"journal-article","created":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T09:06:36Z","timestamp":1172480796000},"page":"273-280","source":"Crossref","is-referenced-by-count":42,"title":["Interpretation, accuracy and management implications of FDG PET\/CT in cutaneous malignant melanoma"],"prefix":"10.1097","volume":"28","author":[{"given":"Matthew S.","family":"Falk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne K.","family":"Truitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus V.","family":"Coakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Kashani-Sabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall A.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Franc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210212","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4065\/81.4.500","article-title":"Cutaneous malignant melanoma","volume":"81","author":"Cummins","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R3-8-20210212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R4-8-20210212","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R5-8-20210212","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0022-4804(91)90056-R","article-title":"[14C]deoxyglucose uptake and imaging in malignant melanoma","volume":"50","author":"Kern","year":"1991","journal-title":"J Surg Res"},{"key":"R6-8-20210212","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/1097-0142(19910315)67:6<1544::AID-CNCR2820670614>3.0.CO;2-0","article-title":"18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography","volume":"67","author":"Wahl","year":"1991","journal-title":"Cancer"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1148\/radiology.195.3.7753998","article-title":"Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose","volume":"195","author":"Steinert","year":"1995","journal-title":"Radiology"},{"key":"R8-8-20210212","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.1998.16.5.1770","article-title":"Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma","volume":"16","author":"Macfarlane","year":"1998","journal-title":"J Clin Oncol"},{"key":"R9-8-20210212","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1664::AID-CNCR11>3.0.CO;2-2","article-title":"Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients","volume":"82","author":"Rinne","year":"1998","journal-title":"Cancer"},{"key":"R10-8-20210212","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.0007-0963.2004.05870.x","article-title":"Baseline staging in cutaneous malignant melanoma","volume":"150","author":"Hafner","year":"2004","journal-title":"Br J Dermatol"},{"key":"R11-8-20210212","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.semnuclmed.2004.06.001","article-title":"Clinical use of positron emission tomography in the management of cutaneous melanoma","volume":"34","author":"Friedman","year":"2004","journal-title":"Semin Nucl Med"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10434-999-0398-4","article-title":"Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma","volume":"6","author":"Wagner","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"R13-8-20210212","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mjd.2000.101448","article-title":"The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma","volume":"42","author":"Acland","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R14-8-20210212","first-page":"1491","article-title":"Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma","volume":"41","author":"Crippa","year":"2000","journal-title":"J Nucl Med"},{"key":"R15-8-20210212","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/1097-0142(20000901)89:5<1019::AID-CNCR11>3.0.CO;2-0","article-title":"Positron emission tomography scanning in malignant melanoma","volume":"89","author":"Tyler","year":"2000","journal-title":"Cancer"},{"key":"R16-8-20210212","first-page":"1420","article-title":"Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma","volume":"34","author":"Gritters","year":"1993","journal-title":"J Nucl Med"},{"key":"R17-8-20210212","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF02574480","article-title":"Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients","volume":"9","author":"Swetter","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"R18-8-20210212","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/01.rlu.0000099805.36471.aa","article-title":"The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making","volume":"28","author":"Gulec","year":"2003","journal-title":"Clin Nucl Med"},{"key":"R19-8-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00006231-199903000-00008","article-title":"Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis","volume":"20","author":"Dietlein","year":"1999","journal-title":"Nucl Med Commun"},{"key":"R20-8-20210212","first-page":"446","article-title":"F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods","volume":"41","author":"Krug","year":"2000","journal-title":"Acta Radiol"},{"key":"R21-8-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1095-0397(00)00073-X","article-title":"7. Survey of results of whole body imaging using the PET\/CT at the University of Pittsburgh Medical Center PET Facility","volume":"3","author":"Martinelli","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"R22-8-20210212","first-page":"1200","article-title":"Clinical performance of PET\/CT in evaluation of cancer: additional value for diagnostic imaging and patient management","volume":"44","author":"Bar-Shalom","year":"2003","journal-title":"J Nucl Med"},{"key":"R23-8-20210212","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.03.5634","article-title":"Diagnostic performance of whole body dual modality 18F-FDG PET\/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients","volume":"24","author":"Reinhardt","year":"2006","journal-title":"J Clin Oncol"},{"key":"R24-8-20210212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0010-4825(00)00006-8","article-title":"A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement","volume":"30","author":"Mackinnon","year":"2000","journal-title":"Comput Biol Med"},{"key":"R25-8-20210212","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1245\/ASO.2006.02.007","article-title":"Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases","volume":"13","author":"Bastiaannet","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s002590050593","article-title":"Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck","volume":"26","author":"Hustinx","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"R27-8-20210212","first-page":"1412","article-title":"Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes","volume":"42","author":"Zhuang","year":"2001","journal-title":"J Nucl Med"},{"key":"R28-8-20210212","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s002590100537","article-title":"Advantage of delayed whole-body FDG-PET imaging for tumour detection","volume":"28","author":"Kubota","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R29-8-20210212","first-page":"957","article-title":"Role of nuclear medicine in the management of cutaneous malignant melanoma","volume":"47","author":"Belhocine","year":"2006","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-200704000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:43:46Z","timestamp":1618037026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-200704000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3280708ecf","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}